One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
ﻗﯿﻤﺖ : 300$- ﻗﯿﻤﺖ ﻭﯾﮋﻩ : 100$
Endometriosis: addressing the roots of slow progress
doi : 10.1016/S0140-6736(24)02179-2
Volume 404, Issue 10460, 5–11 October 2024, Page 1279
Rechallenging with anti-PD-1 therapy in advanced renal cell carcinoma
Honouring our ancestors to advance health justiceUché Blackstock , Legacy: A Black Physician Reckons with Racism in Medicine, Viking/Penguin Random House (2024), p. 304, US$28·00, ISBN: 9780593491287
Medicines from the gardenModern Medicines from Plants: Botanical Histories of Some of Modern Medicine's Most Important Drugs, Henry Oakeley (Ed.), Royal College of Physicians, Routledge (2024), p. 394, £28·99, ISBN: 9781032536170
Renaming mpox in Spanish, French, and Portuguese: using language to address stigma and racism
New WHO INN for cell-based and gene-based substances: timing, usage, and simplicity
Nigeria's new policy: solution for the health-care workforce crisis?
Tivozanib plus nivolumab versus tivozanib monotherapy in patients with renal cell carcinoma following an immune checkpoint inhibitor: results of the phase 3 TiNivo-2 Study
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
Effects of oral sepiapterin on blood Phe concentration in a broad range of patients with phenylketonuria (APHENITY): results of an international, phase 3, randomised, double-blind, placebo-controlled trial
Delayed immune tolerance through donor haematopoietic stem cell infusion 14 months after kidney transplantation
WHO shapes priorities for medicines? An analysis of the applicants and decision makers within the historical evolution of the WHO Model Lists of Essential Medicines
